International Clinical Trial: Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526506) titled 'Study of TRX-100 Tablets Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy Volunteers' on April 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Traws Pharma, Inc.

Condition: Healthy Volunteer

Intervention: Drug: TRX-100 or placebo

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: March 25, 2026

Target Sample Size: 24

Countries of Recruitment: Australia

To know more, visit https://clinicaltrials.gov/study/NCT075...